Post-traumatic stress disorder: emerging concepts of pharmacotherapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Opinion on Emerging Drugs

• Publication date

  2009-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1517/14728210902972494PMID 19453285PMCID PMC2791537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)

  2010cited by this paper
• Genetic variation in 5HTTLPR is associated with emotional resilience

  2009cited by this paper
• Role of Dorsomedial Hypothalamic Neuropeptide Y in Modulating Food Intake and Energy Balance

  2009cited by this paper
• Pharmacotherapy for post-traumatic stress disorder

  2009cited by this paper
• A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

  2009cited by this paper
• Toward validation of the diagnosis of posttraumatic stress disorder.

  2009cited by this paper
• The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans

  2009cited by this paper
• The epidemiology of anxiety disorders in the Arab world: a review.

  2009cited by this paper
• Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.

  2008cited by this paper
• Posttraumatic stress disorder; combat exposure; and nicotine dependence, alcohol dependence, and major depression in male twins.

  2008cited by this paper
• Assessing mental health and psychosocial status in communities exposed to traumatic events: Sri Lanka as an example.

  2008cited by this paper
• Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic–Adrenal–Pituitary Axis Activity or Hyperthermia

  2008cited by this paper
• Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety

  2008cited by this paper
• Drug targeting to the brain

  2008cited by this paper
• Common genetic liability to major depression and posttraumatic stress disorder in men.

  2008cited by this paper
• The Role of Neuropeptide Y in the Expression and Extinction of Fear-Potentiated Startle

  2008cited by this paper
• Optimizing inhibitory learning during exposure therapy.

  2008cited by this paper
• Neural Mechanisms of Extinction Learning and Retrieval

  2008cited by this paper
• Chronic cannabinoid administration in vivo compromises extinction of fear memory.

  2008cited by this paper
• Divalproex in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial in a Veteran Population

  2008cited by this paper
• Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.

  2008cited by this paper
• Main traumatic events in Europe: PTSD in the European study of the epidemiology of mental disorders survey.

  2008influential reference
• Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder

  2008cited by this paper
• The developmental mental-disorder histories of adults with posttraumatic stress disorder: a prospective longitudinal birth cohort study.

  2008influential reference
• The descriptive epidemiology of commonly occurring mental disorders in the United States.

  2008cited by this paper
• Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.

  2008cited by this paper
• A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

  2008cited by this paper
• Genetics of post‐traumatic stress disorder: Informing clinical conceptualizations and promoting future research

  2008cited by this paper
• A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.

  2008cited by this paper
• The molecular neurobiology of depression

  2008cited by this paper
• Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach.

  2008cited by this paper
• Early intervention for trauma: where are we and where do we need to go? A commentary.

  2008influential reference
• Psychobiologic Predictors of Disease Mortality After Psychological Trauma: Implications for Research and Clinical Surveillance

  2008cited by this paper
• Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder.

  2008cited by this paper
• Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.

  2008influential reference
• Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder.

  2008cited by this paper
• A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.

  2008cited by this paper
• Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior

  2008cited by this paper
• Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder

  2008cited by this paper
• AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.

  2008cited by this paper
• A second look at prior trauma and the posttraumatic stress disorder effects of subsequent trauma: a prospective epidemiological study.

  2008influential reference
• Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

  2008cited by this paper
• Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.

  2008cited by this paper
• Post‐Traumatic Stress Disorder in Canada

  2008cited by this paper
• Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I: HPA axis responses.

  2008cited by this paper
• Physical and Mental Comorbidity, Disability, and Suicidal Behavior Associated With Posttraumatic Stress Disorder in a Large Community Sample

  2007cited by this paper
• A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.

  2007cited by this paper
• A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans.

  2007cited by this paper
• Searching for rational anti N-methyl-D-aspartate treatment for depression.

  2007cited by this paper
• How can drug discovery for psychiatric disorders be improved?

  2007cited by this paper
• Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.

  2007cited by this paper
• Strategies to Improve Drug Delivery Across the Blood-Brain Barrier

  2007cited by this paper
• Australian Guidelines for the Treatment of Adults with Acute Stress Disorder and Post-Traumatic Stress Disorder

  2007cited by this paper
• Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview

  2007cited by this paper
• Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.

  2007cited by this paper
• Dopamine beta‐hydroxylase (DBH) activity and ‐1021C/T polymorphism of DBH gene in combat‐related post‐traumatic stress disorder

  2007cited by this paper
• Pretrauma cognitive ability and risk for posttraumatic stress disorder: a twin study.

  2007cited by this paper
• Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war.

  2007cited by this paper
• Mechanisms of fear extinction

  2007cited by this paper
• The Efficacy and Tolerability of Tiagabine in Adult Patients With Post-Traumatic Stress Disorder

  2007cited by this paper
• Drug Targeting to the Brain

  2007cited by this paper
• Propranolol and the Prevention of Post-Traumatic Stress Disorder: Is it Wrong to Erase the “Sting” of Bad Memories?

  2007cited by this paper
• Oxytocin attenuates amygdala responses to emotional faces regardless of valence.

  2007cited by this paper
• Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients.

  2007cited by this paper
• The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults.

  2007cited by this paper
• Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

  2007cited by this paper
• Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.

  2007cited by this paper
• Physiology and neurobiology of stress and adaptation: central role of the brain.

  2007cited by this paper
• Facilitation of Extinction Learning for Contextual Fear Memory by PEPA: A Potentiator of AMPA Receptors

  2007cited by this paper
• Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.

  2007cited by this paper
• Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses

  2007cited by this paper
• Trauma Exposure and Stress Response: Exploration of Mechanisms of Cause and Effect

  2007cited by this paper
• Group II metabotropic glutamate receptors in anxiety circuitry: Correspondence of physiological response and subcellular distribution

  2007cited by this paper
• A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

  2007cited by this paper
• PTSD symptom trajectories: from early to chronic response.

  2007cited by this paper
• Systemic and Intra-Amygdala Administration of Glucocorticoid Agonist and Antagonist Modulate Extinction of Conditioned Fear

  2006cited by this paper
• Longitudinal Studies of PTSD: Overview of Findings and Methods

  2006cited by this paper
• Post-Traumatic Stress Disorder: The Management of PTSD in Adults and Children in Primary and Secondary Care

  2006cited by this paper
• Postreactivation Glucocorticoids Impair Recall of Established Fear Memory

  2006cited by this paper
• Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

  2006cited by this paper
• Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats.

  2006cited by this paper
• Noradrenergic Signaling in the Amygdala Contributes to the Reconsolidation of Fear Memory

  2006cited by this paper
• Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Glucocorticoid Release and Memory Consolidation in Men and Women

  2006cited by this paper
• Pharmacotherapy for post traumatic stress disorder (PTSD)

  2006influential reference
• Pharmacotherapy for post traumatic stress disorder (PTSD).

  2006cited by this paper
• Pharmacotherapy of post-traumatic stress disorder.

  2006cited by this paper
• Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

  2006cited by this paper
• Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists.

  2006cited by this paper
• Advances in Understanding Neuroendocrine Alterations in PTSD and Their Therapeutic Implications

  2006cited by this paper
• Psychosocial therapy for posttraumatic stress disorder.

  2006cited by this paper
• Reconsolidation and Extinction of Conditioned Fear: Inhibition and Potentiation

  2006cited by this paper
• The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats

  2006cited by this paper
• Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

  2006cited by this paper
• No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.

  2006cited by this paper
• HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.

  2006cited by this paper
• Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women

  2006cited by this paper
• Venlafaxine Extended Release in Posttraumatic Stress Disorder: A Sertraline- and Placebo-controlled Study

  2006cited by this paper
• The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.

  2005cited by this paper

• An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update.

  2022cites this paper
• Acute Stress Disorder and Post-traumatic Stress Disorder in Individuals Suffering from Burn Injury

  2020cites this paper
• Dynamic Patterns of Threat-Associated Gene Expression in the Amygdala and Blood

  2019cites this paper
• Transmission of posttraumatic stress disorder (PTSD) from father to offspring in families: a narrative review

  2019cites this paper
• Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress

  2018cites this paper
• Suicidal Behavior in Posttraumatic Stress Disorder: Focus on Combat Exposure

  2018cites this paper
• Pharmaceutical and Natural (Exercise) Mechanisms to Mitigate the Negative Impact of PTSD and Chronic Stress on Synaptic Plasticity and Memory

  2017cites this paper
• The expression level of muscarinic M1 receptor subtypes in different regions of rat brain

  2017cites this paper
• Different frequency repetitive transcranial magnetic stimulation (rTMS) for posttraumatic stress disorder (PTSD): A systematic review and meta-analysis.

  2017cites this paper
• Nicotine and Posttraumatic Stress Disorder

  2017cites this paper
• Heart Rate Variability in Neuropsychiatric Disorders

  2016cites this paper
• On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.

  2016influential citation
• Treatments for Post-traumatic Stress Disorder: Pharmaceutical and Electrophysiologic Considerations

  2015cites this paper
• Non-Antidepressant Long-term Treatment in Post-Traumatic Stress Disorder (PTSD).

  2015cites this paper
• D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model.

  2015cites this paper
• Effects of Developmental Abuse and Symptom Suppression among Traumatized Veterans

  2015cites this paper
• Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.

  2014influential citation
• Patient-reported outcomes in post-traumatic stress disorder Part II: Focus on pharmacological treatment

  2014cites this paper
• Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat model

  2014cites this paper
• Intranasal infusion of melanocortin receptor four (MC4R) antagonist to rats ameliorates development of depression and anxiety related symptoms induced by single prolonged stress.

  2013cites this paper
• Participation in outdoor recreation program predicts improved psychosocial well-being among veterans with post-traumatic stress disorder: a pilot study.

  2013cites this paper
• Efectividad de la ketamina en depresión bipolar: revisión sistemática de la literatura

  2013cites this paper
• Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.

  2013cites this paper
• Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder

  2013cites this paper
• Treadmill exercise during pregnancy ameliorates post‑traumatic stress disorder‑induced anxiety‑like responses in maternal rats.

  2013cites this paper
• Antidepressant-Antianxiety Agents

  2013cites this paper
• Chemotherapy in psychiatry

  2013cites this paper
• Pharmacological treatment of PTSD - established and new approaches.

  2012cites this paper
• Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus

  2012cites this paper
• The perioperative implications of posttraumatic stress disorder.

  2012cites this paper
• Course Update for Nurse Anesthetists The Perioperative Implications of Posttraumatic Stress Disorder

  2012cites this paper
• Prevalence of Post-Traumatic Stress Disorders and associated factors among workers attending trauma centers in Jeddah, KSA

  2012cites this paper
• From non-pharmacological interventions to therapeutic targets for the treatment of PTSD

  2012cites this paper
• Post-traumatic stress disorder as a comorbidity: impact on disease outcomes

  2012cites this paper
• The Relationship Between Gabapentin and Pregabalin and Posttraumatic Stress Disorder in Burned Servicemembers

  2012cites this paper
• Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder.

  2012cites this paper
• Acute stress disorder and post traumatic stress disorder in individuals suffering from burn injury

  2012cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Posttraumatic Stress Disorder

  2011cites this paper
• Repetitive transcranial magnetic stimulation and threat memory: selective reduction of combat threat memory p300 response after right frontal-lobe stimulation.

  2011cites this paper
• Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.

  2010cites this paper
• The Psychopharmacology Algorithm Project at The Harvard South Shore Program: An Update on Generalized Social Anxiety Disorder

  2010cites this paper
• Environmental Enrichment Induces Behavioral Recovery and Enhanced Hippocampal Cell Proliferation in an Antidepressant-Resistant Animal Model for PTSD

  2010cites this paper